AI enzyme design and modification software and tool to improving enzyme tolerance to organic solvents is the holy grail of protein engineering—natural enzymes have evolved over billions of years to work in water, but industrial synthesis needs them to perform efficiently in organic environments. AI-driven precision design is turning this trial-and-error art into a predictable science, allowing enzymes to go from 'instantly deactivating' to working stably for hours or even days in solvents like methanol and acetonitrile, completely clearing the final hurdle for industrial-scale biocatalysis.
Aug 20, 2026
The enzyme's enantioselectivity directly determines the optical purity and value of chiral drugs and fine chemicals. The MatwingsVenus platform, through AI-driven broad-site scanning and synergistic effect analysis, breaks through the activity-selectivity trade-off, achieving efficient upgrades from 60% to >99% e.e.
Aug 20, 2026
In industrial biocatalysis, natural enzymes often lose activity in acidic environments—the active site residues get protonated, structural stability drops, and they tend to aggregate. Through directed evolution, rational design, and AI-driven modifications, we can precisely enhance an enzyme's acid resistance by adjusting pKa values, reconfiguring electrostatic networks, and stiffening flexible regions. Moving from a 'trial-and-error' approach to 'multidimensional synergy,' these technologies are giving strong support to the food, feed, pharma, and environmental sectors.
Aug 20, 2026
The thermal stability modification of industrial enzymes determines reaction efficiency and cost. This article breaks down the four main methods (rational design, directed evolution, semi-rational design, and AI-driven design), exploring when to use each and how to choose. It also reveals how the AI-powered MatwingsVenus platform achieves a breakthrough from 'trial and error' to 'precise design.' A complete guide to AI enzyme modification.
Aug 19, 2026Four main strategies for optimizing enzyme activity: directed evolution relies on random mutations and high-throughput screening, semi-rational design precisely targets hotspots, rational design performs precision 'surgery' using structural mechanisms, and AI-assisted design lets computation take the lead to narrow down experiments. Choose the right strategy, iterate and optimize, and boosting efficiency a hundredfold isn't a dream.
Aug 19, 2026
Enzymes are the most efficient catalysts in nature, but industrial applications often require tweaking their substrate specificity—so how can this 'lock' fit more 'keys'? From site-directed mutagenesis to AI-driven design, this article unveils cutting-edge techniques for reshaping enzyme binding pockets and helps you understand the revolutionary evolution of protein engineering.
Aug 19, 2026
Single-point mutations offer limited improvements; real performance jumps come from the synergy of multiple sites. Matwings Venus from Matwings Tech uses AI to predict the effects of combined mutations, turning trial-and-error into rational design, achieving a 10x performance boost, and providing precise solutions for industrial enzyme engineering and protein binding optimization.
Aug 18, 2026High-throughput protein screening refers to evaluating a large number of protein variants (from thousands to billions) for their target properties in a single experiment, and then enriching or isolating the candidates that meet the requirements. The core of it has two parts: genotype-phenotype linkage (knowing which sequence corresponds to which function) and scaled-up reading/sorting (checking a lot of candidates at once).
Aug 18, 2026
Computational biology AI is reshaping the way we discover enzymes: it can pinpoint high-performance enzyme candidates from hundreds of millions of sequences in UniProtKB, and AI screening pushes experimental success rates above 80%, with catalytic activity increasing over 19 times. By integrating BRENDA validation data with AlphaFold structure predictions, this new generation of technology breaks through the limits of traditional BLAST, ushering in an 'AI-first' era of discovering distant enzymes.
Aug 18, 2026
AutoDock Vina is the core tool for virtual screening and molecular docking. The MatwingsVenus platform by Shanghai Matwings Technology makes docking more efficient and standardized through cloud-based no-deployment, AI automatic preprocessing, and flexible computing power, achieving a complete loop from prediction to experimental validation.
Aug 17, 2026From trial-and-error experiments to computation first, AI is now revealing the molecular secrets of protein solubility mutations: which amino acid should you change to avoid 'protein goo'? The MatwingsVenus platform has compressed 5 years of research into 6 months, making designing good proteins as easy as having a conversation.
Aug 17, 2026
The expression level of recombinant proteins determines the lifeline of the biopharmaceutical and enzyme industries. AI design breaks through traditional optimization limits and achieves fundamental improvements in folding dynamics and surface properties through global sequence reconstruction, cutting the R&D cycle from 5 years down to 6 months and reducing unit costs by 50%. Protein expression level optimization mutations; protein binding affinity mutation prediction; protein interface mutation design; protein substrate specificity mutation design; protein selectivity modification mutations.
Aug 17, 2026Analyzing the surface charge of proteins isn’t just a 'nice-to-have' for structural visualization; it’s the 'underlying code' that determines a protein’s solubility, stability, binding specificity, and druggability. Whoever figures it out first will save themselves half the trouble in antibody engineering, enzyme engineering, and AI protein design.
Aug 16, 2026
Active pocket prediction is the starting point of drug development. MatwingsVenus platform by Matwings Tech uses AI to overcome the bottleneck in hidden pocket prediction, achieving a full-process loop from sequence input to functional design, shrinking analyses that used to take weeks into just a few minutes.
Aug 16, 2026
DiffDock overturns the traditional molecular docking paradigm, achieving a 38% top-1 success rate for blind docking breakthroughs, showing the unique value of AI generative models in predicting new targets and allosteric sites.
Aug 16, 2026
Build accurate evolutionary trees with one click: from sequence alignment to smart visualization, the MatwingsVenus™ (XiaoWu™) platform combines cloud computing power and AI parameter suggestions, cutting protein phylogenetic analysis from days down to just hours, directly tackling the core biological questions of functional evolution and targeted modification.
Aug 13, 2026A lot of people use AlphaFold, but when faced with a structure diagram, they don't know what to do next. The MatwingsVenus™ (XiaoWu™) platform, however, builds on structure prediction and integrates full-chain capabilities from structure quality assessment, functional site mining, stability and property analysis, to intelligent design for directed evolution, making predicted structures actually 'useful' instead of just taking up space on your hard drive.
Aug 13, 2026
How can we judge the reliability of protein structures predicted by AlphaFold? The key is understanding the pLDDT and PAE indicators—deep blue areas are safe to use, yellow areas should be treated with caution. Meanwhile, MatwingsVenus (Xiaowu) is integrating structure interpretation, functional annotation, and protein design into a full-process smart R&D workflow.
Aug 13, 2026
When it comes to clustering millions of protein sequences, traditional tools are limited by computing power and technical barriers. The new-generation online platform MatwingsVenus combines large model embeddings for clustering, completing analyses in minutes and generating interactive reports with a single click, turning massive data into biological insights instantly.
Aug 12, 2026
Accurately identifying conserved sites in proteins is key to understanding their function and guiding targeted modifications. From multiple sequence alignment to AI-powered analysis, mastering these essential methods can really boost your research efficiency.
Aug 12, 2026Multiple sequence alignment is the starting point for almost all protein sequence analysis. Sequence annotation, function prediction, homology modeling, evolutionary analysis... almost all downstream analyses are built on a high-quality multiple sequence alignment. That's also why 'how to do protein multiple sequence alignment' is a basic skill every bioinformatician can't avoid.
Aug 12, 2026
In today's age of exploding proteomics data, Matwings Technology's MatwingsVenus platform uses a massive sequence database and protein language models to provide an all-in-one analysis from amino acid sequences to functional annotation and active site prediction, compressing traditional multi-month experimental cycles down to minutes, offering efficient and smart solutions for synthetic biology and drug development.
Aug 11, 2026How can AI crack the ultimate code linking protein sequences to their functions? From AlphaFold's breakthroughs to AI-driven enzyme engineering, we're standing at the forefront of a protein engineering revolution—how does an amino acid sequence determine function? Structure prediction is just the start; the real challenge lies in understanding the complex mapping from sequence to function.
Aug 11, 2026
Protein sequence analysis no longer requires constantly switching tools—MatwingsVenus puts AI at the core, enabling parallel searches across 30 databases, and lets natural language drive design and experiments, cutting the traditional 2-5 year R&D cycle down to 2-6 months, making 'chat-based protein development' a reality.
Aug 11, 2026
Protein G has become the preferred choice for antibody purification thanks to its broader species compatibility and lower non-specific binding. The key to selecting it: use pre-packed columns for small samples and be flexible with bulk resin for larger samples. AI-designed domestic Protein G products have made breakthroughs in capacity, stability, and cost, supporting both research and industrial-scale purification.
Aug 11, 2026The key to the million-dollar cost of gene therapy lies in purification—AAV affinity chromatography media acts like a precise molecular key, capturing the target virus in one step and boosting purity by over 90%. AI agents are reshaping the way we develop these resins, making high-efficiency purification no longer a bottleneck.
Aug 11, 2026
For full IgG and other antibodies with the complete Fc region, Protein A resins are preferred since they offer higher industrial capacity and a more mature process. For Fab, scFv, and other antibodies without an Fc fragment, you have to use Protein L resins for Fab or Protein L resins for scFv purification.
Aug 11, 2026
Traditional Protein A resins can't purify new types of antibodies? κ light chain affinity resins are exactly that 'second key,' specially solving purification challenges for Fab fragments, bispecific antibodies, and more. With AI optimization, their performance is even stronger, coverage is broader, helping you break through process bottlenecks.
Aug 10, 2026
For rabbit IgG, Protein A is the first choice. For human IgG1/2/4, use Protein A, and for IgG3, go with Protein G — picking the right resin can boost antibody recovery by 30%. AI-designed affinity chromatography materials are tailored to match subtype characteristics, solving the IgG3 purification challenge.
Aug 9, 2026The core battlefield of gene therapy is hidden in the little 'bottles and jars' of AAV fillers—ranging from star vectors in the hundred-billion-level market to the tough purification tests. With just one step, affinity fillers that can capture high-purity AAV are breaking the industry's 'no fillers available' dilemma through AI-driven precision design.
Aug 9, 2026
Protein A resin has very weak binding ability to rodent IgG subclasses, like those from mice and rats, so it’s not suitable for purifying rodent antibodies. On the other hand, Protein G resin, with its broad species compatibility, has become a go-to choice for purifying IgG across multiple species, making it the key solution for the tricky task of selecting resins for mouse and rat IgG purification.
Aug 6, 2026Protein A pre-packed columns, chromatography columns, capture steps, and process development: A full breakdown of antibody purification from lab to mass production;The global chromatography media market is expected to reach $3 billion by 2025. Protein A, as the core technology for antibody purification, can boost antibody purity to over 95% in just one capture step. Domestic alternatives are speeding up, and AI technology is reshaping Protein A media development, pushing China's antibody industry towards greater self-reliance.
Aug 6, 2026
Protein L breaks the traditional Fc-dependent antibody recognition mechanism. By binding to the variable region of the κ light chain, it can efficiently capture antibodies, perfectly matching new antibody drugs like Fab and scFv that lack Fc structures, making it a key material for industrial purification. AI-driven ligand optimization also gives it high load capacity, alkali resistance, and precise separation ability, pushing antibody drug production into the era of smart manufacturing.
Aug 6, 2026
Protein L resin breaks through the limitations of traditional antibody purification. By binding to the κ light chain variable region, it creates an efficient purification path for antibody fragments without Fc structures, like Fab, scFv, and bispecific antibodies, making it an indispensable tool in new antibody drug development. Protein L resin; Protein L resin suppliers.
Aug 5, 2026
Protein G affinity ligands, with their broad-spectrum antibody binding, low non-specific adsorption, and flexible elution features, have become a key solution for purifying antibodies from multiple species. The AI-optimized version breaks through traditional performance limits, achieving a balance of high stability and high specificity, covering all scenarios in research, diagnostics, and biomanufacturing. Protein G affinity ligand manufacturers.
Aug 5, 2026
Protein G affinity media, with its broader antibody binding ability and lower non-specific adsorption, has become a core material for research diagnostics and antibody purification. It's especially useful for subtypes that Protein A struggles to capture, like human IgG3 and mouse IgG1. Recombinant Protein G, designed with AI, further improves binding capacity, alkali resistance, and specificity, making antibody purification more efficient and stable.
Aug 4, 2026The core of commercializing antibody drugs lies in Protein A resins—from the high load demands of lab-scale process scale-up to cost control in large-scale production, every step relies on the resin's precise performance. AI-powered MatwingsVenus is reshaping this tech foundation, helping domestic resins overcome both performance and supply chain barriers.
Aug 4, 2026
The traditional strong-acid elution mode of Protein A affinity chromatography is being disrupted by the mild pH 5 elution technique! The new monomer-protected resin allows sensitive molecules like bispecific and polyclonal antibodies to avoid structural collapse, enabling high-load purification at higher pH, preventing aggregation from the start, and improving both yield and purity.
Aug 4, 2026
China Protein A resins are moving from being a 'cheap alternative' to a 'high-quality alternative.' AI-assisted ligand design has shortened the R&D cycle from 2-5 years to 2-6 months and reduced the number of experimental samples by over 90%, becoming a key technological breakthrough for breaking import monopolies and achieving independent control of high-end chromatography resins.
Aug 3, 2026Antibody drug purification technology is going through a revolutionary upgrade: from the classic three-step purification for monoclonal antibodies to special resins for bispecific antibodies/ADCs, the AI-driven MatwingsVenus smart system is reshaping the paradigm of chromatography media design, making high-purity, low-cost production possible — China's path to self-reliant biopharmaceuticals lies in these tiny technical breakthroughs.
Aug 3, 2026
With the development of new antibody drugs, complex molecules like bispecific or multispecific antibodies are extremely sensitive to acidic environments, and traditional strong acid elution processes can easily damage their structure. Purification resins for low pH-sensitive antibodies use ligand engineering and specific modifications to enable gentle high-pH elution and precise impurity removal, solving the industrial purification challenges of acid-sensitive and easily aggregated antibodies and becoming a core technology supporting biopharmaceutical production.
Aug 3, 2026
Biopharmaceutical purification costs account for 50%-80% of total production costs, and custom chromatography fillers combined with AI-designed affinity ligands are becoming key to cost reduction. From standardization to personalization, next-generation purification technologies will break through the process bottlenecks of complex drugs such as bispecific antibodies and ADCs. The MatwingsVenus platform enables efficient customization through AI wet and dry loops, driving a paradigm upgrade in biomanufacturing.
Aug 2, 2026The gold standard for antibody purification is Protein A affinity chromatography, and its core lies in the precise 'molecular handshake' between the Fc region and the ligand — this conservation amid all the variations makes it possible to achieve 95% purity in just one purification step, supporting the massive production capacity of the global antibody industry. From natural proteins to AI-designed engineered ligands, every breakthrough at the molecular level is reshaping the efficiency limits of biomanufacturing.
Aug 2, 2026
Low-aggregation Protein A resins are shaking up antibody purification. With gentle elution and smart separation working together, they directly remove 70% of aggregates during the capture stage, protecting antibody activity while boosting purity. It's not just a tech upgrade—it’s a leap from fixing problems after the fact to controlling them right from the source.
Aug 2, 2026
Traditional Protein A purification relies on low pH elution, which can cause antibody aggregation and loss of activity. The new high pH elution media break through this technical bottleneck, allowing efficient dissociation under mild conditions of pH 4.0-5.0. This provides a safer purification solution for complex molecules like bispecific antibodies, balancing both yield and quality improvements.
Jul 30, 2026
From natural extraction to AI design, the iteration of affinity ligands is taking biopharmaceutical purification from a 'trial-and-error' stage to a 'custom-on-demand' era. Protein large models break through the limitations of natural sequences, making it possible to design original ligands that are alkali-resistant, high-loading, and super-specific, completely reshaping the technical barriers and industry logic of the filler sector.
Jul 30, 2026Protein A resin is the 'gold standard' starting point in the antibody industry, capturing antibodies in one step with over 95% purity, supporting the production of hundreds of monoclonal antibody drugs worldwide. AI-driven custom design is speeding up the development of the next generation of high-performance resins, making antibody purification more efficient and accurate.Protein A resin for antibody capture;Protein A resin for mAb capture;Protein A resin for mAb purification;Protein A resin for IgG purification
Jul 30, 2026
mild elution Protein A resin; mild pH elution Protein A resin; A Flexible Revolution in Antibody Purification
Jul 30, 2026
GMP-grade chromatography resin; antibody capture resin; capture chromatography resin; affinity ligand protein
Jul 29, 2026low ligand leakage Protein A resin; low Protein A leaching resin; high-flow Protein A resin; high-throughput Protein A resin supplies and manufacturer
Jul 29, 2026